ANTARES PHARMA, INC. 4
4 · ANTARES PHARMA, INC. · Filed Jun 1, 2015
Insider Transaction Report
Form 4
Stacey Jennifer Evans
SVP, General Counsel & Secty
Transactions
- Tax Payment
Common Stock
2015-05-28$2.18/sh−2,469$5,382→ 21,803 total - Award
Stock option (right to buy)
2015-05-28+142,550→ 142,550 totalExercise: $2.18Exp: 2025-05-27→ Common Stock (142,550 underlying) - Award
Common Stock
2015-05-28+70,239→ 92,042 total
Footnotes (4)
- [F1]The shares reported here represent the total number of securities beneficially owned following the reported transaction, excluding awards of performance stock units previously reported as 48,544 shares of common stack that remain subject to the achievement of a performance goal pursuant to the terms of the award and thus were removed from the total amount of securities beneficially owned.
- [F2]Represents grant of restricted stock units made under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F3]Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- [F4]The options vest in equal quarterly installments over three years from the date of grant.